Current location:style >>
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
style295People have gathered around
IntroductionWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the b ...
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“International Intervals news portal”。http://martinique.shellye-mcdaniel.com/content-51c299651.html
Related articles
FDIC chairman Martin Gruenberg to step down, White House says
styleNEW YORK (AP) — The White House said Monday that the chairman of the Federal Deposit Insurance Corpo ...
【style】
Read moreChina ‘disappointed' as US blocks Gaza ceasefire for 4th time at UN
styleA woman holds a flag and a blue smoke bomb next to police officers as protesters demonstrate outside ...
【style】
Read moreBeijing slams Washington for spreading false info
styleUS Secretary of State Antony Blinken. [Photo/Agencies]Beijing hit back at Washington's slandering of ...
【style】
Read more
Popular articles
- Brewers starter Joe Ross leaves after first inning vs. Marlins with lower back strain
- Albanese's visit boosts China
- European leaders hit back at Macron remark
- Trump's historic hush money trial begins with jury selection
- DR MARTIN SCURR: How losing your hearing may cause dementia
- Multiple safety issues haunt Boeing
Latest articles
Digital technologies restore looks of 2,200
Support workshops facilitate employment for workers at their doorsteps
China Focus: China Issues No. 1 Central Document for 2023, Highlights Rural Vitalization Tasks
Xi Holds Talks with Belarusian President
Tamara Ecclestone is criticised as her daughter Fifi, 10, heads out wearing heavy make
Industry sees OpenAI's Sora as a game changer
LINKS
- China, UN co
- Weaponization of human rights slammed
- China to continue to prioritize employment promotion
- China slams India's tunnel inauguration in border area
- U.S. chip firms urge Biden administration to approve sales to China as ban backfires
- Ministry: U.S. practice disrupts normal business activities
- FM: China supports int'l peace conference on Ukraine crisis
- China announces visa
- China prepares to boost multiple sectors to help develop innovative talent
- Washington manipulates freedom of speech, report finds